PROFILING OF EGFR POSITIVE MUTATION LUNG ADENOCARCINOMA IN A MALAYSIAN TERTIARY CENTRE: A PRELIMINARY DATA

被引：0
|
作者：
Esa, N. Y. Mohd [1 ]
Musa, A. N. [1 ]
Isa, M. R. [1 ]
Nordin, N. [1 ]
Zim, M. A. Mohd [1 ]
Ismail, A. I. [1 ]
机构：
[1] Univ Teknol MARA UiTM, Internal Med, Sungai Buloh, Malaysia
来源：
RESPIROLOGY | 2016年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
APSR6-0608
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [1] Mutational signatures in EGFR sensitizing mutation positive lung adenocarcinoma
    Kim, Eun Young
    Kim, Arum
    Chang, Yoon Soo
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Women with adenocarcinoma of the lung:: Frequency of EGFR-mutation.: A preliminary report
    Tedesco, B.
    Migliorino, R.
    Graziano, P.
    Leone, A.
    De Santis, S.
    Condo, S.
    Di Salvia, M.
    De Marinis, F.
    ANNALS OF ONCOLOGY, 2007, 18 : 34 - 35
  • [3] Feasibility and outcome of repeat biopsy upon progression on tyrosine kinase inhibitors in patients with EGFR mutation positive adenocarcinoma of lung-an Indian tertiary cancer centre experience
    Zanwar, Saurabh
    Noronha, Vanita
    Joshi, Amit
    Patil, Vijay Maruti
    Chougule, Anuradha
    Janu, Amit
    Kumar, Rajiv
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Concomitant Driver Mutation Determines Tumor Growth in EGFR Mutation-Positive Lung Adenocarcinoma
    Nagayama, Kazuhiro
    Karasaki, Takahiro
    Kuwano, Hideki
    Nitadorti, Jun-Ichi
    Sato, Masaaki
    Anraku, Masaki
    Matsushita, Hirokazu
    Kakimi, Kazuhiro
    Nakajima, Jun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S508 - S509
  • [5] Miliary cerebral carcinomatosis secondary to EGFR mutation-positive lung adenocarcinoma
    Dumoulin, J.
    Rozensztajn, N.
    Paradis, M.
    Sellier, J.
    Abel, A.
    Giraud, P.
    Labrune, S.
    Chinet, T.
    REVUE DES MALADIES RESPIRATOIRES, 2016, 33 (01) : 67 - 71
  • [6] Osimertinib for the Treatment of EGFR Mutation-Positive Lung Adenocarcinoma Complicated With Dermatomyositis
    Yamasaki, Masahiro
    Matsumoto, Naoko
    Nakano, Shota
    Kawamoto, Kazuma
    Taniwaki, Masaya
    Izumi, Yusuke
    Otohara, Masaya
    Nabeshima, Shinji
    Ohashi, Nobuyuki
    Hattori, Noboru
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (12): : 822 - 823
  • [7] EGFR MUTATION STATUS IN ADENOCARCINOMA LUNG: A SINGLE CENTRE EXPERIENCE FROM NORTHERN INDIA
    Wadhwa, Jyoti
    Jandya, Sunny
    Batra, Sandeep
    Sharma, Neelam
    Sharma, Devender
    Gupta, Atul
    Puri, Rohit
    Singh, Bhanu P.
    Bali, San-Deep
    Raina, Vimarsh
    Vaid, Ashok K.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S606 - S606
  • [8] The effect of anticancer chemotherapeutics on immune microenvironment of lung adenocarcinoma with EGFR mutation in vivomicroenvironment of lung adenocarcinoma with EGFR mutation in vivo
    Suh, Young-Ah
    Mun, Hyemin
    Lee, Sun-Hye
    Jo, Se-Young
    Oh, Ju-Hee
    Lee, Chu-Hee
    CANCER RESEARCH, 2018, 78 (13)
  • [9] EGFR mutation signature in lung adenocarcinoma.
    Lamlertthon, Wisut
    Weiss, Jared
    Wilkerson, Matthew
    Hayward, Michele C.
    Hayes, David N.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Diffuse Metastases of Lung Adenocarcinoma with EGFR mutation
    Kunimasa, Kei
    Masuda, Gen
    Watanabe, Naoki
    Ishida, Tadashi
    INTERNAL MEDICINE, 2012, 51 (06) : 685 - 686
12345